Topic
Atrial Fibrillation
This collection features the best content from AFP, as identified by the AFP editors, on atrial fibrillation and related issues, including anticoagulation therapy, antiplatelet therapy, arrhythmias, and palpitations. New research may affect the interpretation and application of this material. Clinical judgment is advised. Note that AFP content published within the past two years is accessible to AAFP members and paid subscribers only.
Overview
Screening and Diagnosis
Treatment
Acute
Chronic
Nov 15, 2023 |
— |
Class I and III Antiarrhythmic Drugs for Maintaining Sinus Rhythm After Catheter Ablation of Atrial Fibrillation
[Cochrane for Clinicians]
CME
|
Jun 15, 2020 |
— |
Anticoagulation in Older Adults
[Lown Right Care]
|
Oct 01, 2019 |
— |
Effectiveness and Safety of Factor Xa Inhibitors in Patients with Atrial Fibrillation
[Cochrane for Clinicians]
|
Oct 01, 2019 |
— |
Anticoagulation: Updated Guidelines for Outpatient Management
|
Apr 15, 2019 |
— |
Bridging Warfarin Before Colonoscopy in Patients with Atrial Fibrillation
[FPIN's Clinical Inquiries]
|
Apr 01, 2019 |
— |
Direct Oral Anticoagulants vs. Warfarin to Prevent Stroke and Embolic Events in Patients with Atrial Fibrillation and CKD
[Cochrane for Clinicians]
|
Dec 15, 2018 |
— |
Evaluating the Benefits and Harms of Anticoagulation in Patients with Atrial Fibrillation
[Point-of-Care Guides]
|
Jul 01, 2018 |
— |
Bleeding with Anticoagulants: ACC Releases Expert Consensus Decision Pathway to Guide Management
[Practice Guidelines]
|
Apr 15, 2018 |
— |
Edoxaban (Savaysa) for the Prevention of Thromboembolic Events
[STEPS]
|
Oct 01, 2017 |
— |
Assessing Bleeding Risk in Patients Taking Anticoagulants
[Point-of-Care Guides]
POC
Tool
|
Jun 15, 2017 |
— |
Idarucizumab (Praxbind) for Dabigatran (Pradaxa) Anticoagulant Reversal
[STEPS]
|
Jun 01, 2017 |
— |
Self-Monitoring and Self-Management of Oral Anticoagulation
[Cochrane for Clinicians]
Tool
|
Oct 01, 2016 |
— |
Rivaroxaban vs. Warfarin for Anticoagulation in Patients with Atrial Fibrillation Undergoing Ablation and Cardioversion
[Medicine by the Numbers]
|
Apr 15, 2014 |
— |
Apixaban (Eliquis) for Stroke Prevention in Atrial Fibrillation
[STEPS]
|
Oct 15, 2012 |
— |
Chronic Atrial Fibrillation
[Clinical Evidence Handbook]
|
Oct 15, 2012 |
— |
Rivaroxaban (Xarelto) for Prevention of Thromboembolic Events
[STEPS]
|
Mar 15, 2012 |
— |
Rivaroxaban vs. Warfarin for Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation
[AFP Journal Club]
|
Dec 15, 2011 |
— |
Dabigatran (Pradaxa) for Prevention of Stroke in Atrial Fibrillation
[STEPS]
|
May 01, 2008 |
— |
Oral Anticoagulants vs. Antiplatelet Therapy
[Cochrane for Clinicians]
|
Feb 15, 2005 |
— |
Evidence-Based Initiation of Warfarin (Coumadin)
[Point-of-Care Guides]
Alg
POC
|
Sep 01, 2004 |
— |
Which Patients with Atrial Fibrillation Do Not Need Anticoagulation Therapy with Warfarin?
[FPIN's Clinical Inquiries]
|
Improving Practice
Patient Education, Self-Care
Other Resources from AAFP